In short, our data demonstrate that miR‐515‐5p dramatically inhibits cell migration by directly down‐regulating MARK4 expression in two different cancer types and suggests a role for miR‐515‐5p and MARK4 as potential biomarkers in metastatic disease and as possible therapeutic targets. This evidence concerns the gene MARK4 and metastatic neoplasm.